Show simple item record

Treatments for Squamous Cell Cancer

dc.contributor.editorDarido, Charbel
dc.date.accessioned2023-02-20T16:43:14Z
dc.date.available2023-02-20T16:43:14Z
dc.date.issued2022
dc.identifierONIX_20230220_9783036547589_15
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/97412
dc.description.abstractSquamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an updated snapshot on our understanding of the heterogeneity of SCC pathogenesis with novel opportunities in precision therapeutics to achieve better clinical outcomes.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncologyen_US
dc.subject.othern/a
dc.subject.otheroral cancer
dc.subject.othertobacco
dc.subject.otheralcohol
dc.subject.otherhuman papilloma virus
dc.subject.othertargeted sequencing
dc.subject.otherDNA copy number
dc.subject.otherTP53
dc.subject.otherCDKN2A
dc.subject.otherEGFR
dc.subject.otherPIK3CA
dc.subject.otheranal cancer
dc.subject.otherradiation therapy
dc.subject.otherchemoradiation
dc.subject.otherde-escalation of therapy
dc.subject.otherpain
dc.subject.othercathepsin S
dc.subject.otherprotease-activated receptor-2
dc.subject.otherPAR2
dc.subject.othercancer pain
dc.subject.otheroral squamous cell carcinoma
dc.subject.otherdifferentiation
dc.subject.otherterminal differentiation
dc.subject.otheroral epithelium
dc.subject.otherepithelial integrity
dc.subject.otherepithelial transformation
dc.subject.othergenetic alterations
dc.subject.othertherapy response biomarkers
dc.subject.othercutaneous squamous cell carcinoma
dc.subject.otherimmunotherapy
dc.subject.otheranti-PD1
dc.subject.otherbiomarkers
dc.subject.otherpredictive medicine
dc.subject.otherpersonalized medicine
dc.subject.othercancer
dc.subject.otherimmune system
dc.subject.otherHNSCC
dc.subject.otherfarnesyl transferase
dc.subject.othertipifarnib
dc.subject.othercombination regimen
dc.subject.otheroropharynx
dc.subject.otherneoplasm
dc.subject.othersquamous cell carcinoma
dc.subject.otherhuman papillomavirus
dc.subject.othertherapeutic management
dc.subject.othertreatment selection
dc.subject.otherCSCC
dc.subject.othertreatment
dc.subject.otheradvances
dc.subject.otherbiology
dc.subject.otherimmunocompromised
dc.subject.otherimmune checkpoint inhibition
dc.titleTreatments for Squamous Cell Cancer
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-4757-2
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036547589
oapen.relation.isbn9783036547572
oapen.pages168
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/